ARCADIA INVESTMENT MANAGEMENT CORP/MI - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 27 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARCADIA INVESTMENT MANAGEMENT CORP/MI ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$16,000
-11.1%
12,0000.0%0.00%
-25.0%
Q2 2020$18,000
+63.6%
12,0000.0%0.00%
+33.3%
Q1 2020$11,000
-42.1%
12,0000.0%0.00%
-40.0%
Q4 2019$19,000
-53.7%
12,0000.0%0.01%
-54.5%
Q3 2019$41,000
-6.8%
12,0000.0%0.01%
-8.3%
Q2 2019$44,00012,0000.01%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
PARSONS CAPITAL MANAGEMENT INC/RI 195,165$1,559,0000.21%
DAFNA Capital Management LLC 27,412$219,0000.19%
Verity & Verity, LLC 12,385$99,0000.03%
Baker Brothers Advisors 219,298$1,752,0000.02%
Alyeska Investment Group, L.P. 200,000$1,598,0000.01%
Alyeska Investment Group, L.P. 200,000$1,598,0000.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 97,286$777,0000.01%
BRYN MAWR TRUST Co 14,000$112,0000.01%
BlackRock Investment Management, LLC 163$1,0000.00%
MORGAN STANLEY 12,500$100,0000.00%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders